Ozempic’s list price looks alarming, but most people never pay it. What you actually pay depends almost entirely on which savings path you take — and most people aren’t told about all of them. This guide covers every cost scenario: uninsured, commercially insured, Medicare, and low income — plus the real story on free medication programs, the $25 copay card, and what happened to compounded semaglutide.
Ozempic’s “list price” — the number that gets quoted in news articles — is approximately $936 to $1,219 per month depending on the pharmacy and dose. Almost nobody pays this. The actual out-of-pocket cost splits dramatically based on your situation: with commercial insurance and the manufacturer’s savings card, many people pay $25 per month. Without insurance but with the NovoCare self-pay program, it’s $349 per month for most doses. If you have low enough income and no coverage, it can be $0 through the patient assistance program. The biggest mistake people make is paying the full retail pharmacy price without first checking whether they qualify for any of the programs described on this page.
These are the specific questions most people search but rarely get straight, plain-language answers to. Here they are — based on FDA-approved prescribing information, Novo Nordisk’s published programs, and current pharmacy data.
-
1
How much is Ozempic per month without insurance? List price: $936–$1,219/month (rarely what anyone pays) · NovoCare self-pay: $349/month for 0.25 mg, 0.5 mg, or 1 mg · $499/month for 2 mg · New patient intro offer: $199/month for first 2 months · Pill form: $149–$299/month depending on doseNovo Nordisk — the company that makes Ozempic — now runs its own pharmacy program specifically for uninsured patients. Through NovoCare Pharmacy and participating pharmacies, the self-pay price is $349 per month for the three lower injection doses (0.25 mg, 0.5 mg, and 1 mg) and $499 per month for the 2 mg dose. New patients who have never used the program get an introductory rate of $199 for the first two months on the lower doses. These prices are meaningfully lower than the $936+ list price seen at most retail pharmacies without a discount. The oral Ozempic pill (newer form, same semaglutide ingredient) runs $149 to $299 per month on the self-pay program depending on dose strength. There is currently no generic version of Ozempic available — Novo Nordisk’s patent runs through at least 2031, so no cheaper generic is coming anytime soon.
-
2
What is the $25 Ozempic coupon and who actually qualifies? The $25/month price is through the NovoCare Savings Card · Requires commercial insurance that covers Ozempic · Does NOT work with Medicare, Medicaid, Tricare, or VA · Provides up to $100 in monthly savings · Valid for up to 48 monthsThe $25 monthly price that gets advertised widely is real — but it’s specifically for people who have private commercial health insurance that already covers Ozempic, and who use the NovoCare Savings Card issued by Novo Nordisk. The card covers the gap between what insurance pays and what you owe at the pharmacy, up to $100 per month in savings. If your commercial insurance covers Ozempic and your copay would otherwise be $85/month, the card brings you down to $25. What trips people up: the card is completely off-limits for anyone with government insurance — Medicare, Medicaid, Medicaid managed care, TRICARE, or VA benefits. Federal anti-kickback laws prohibit manufacturer copay cards from being used alongside government programs. If you have Medicare or Medicaid, this particular discount doesn’t apply to you at all. The card also requires no income verification — it’s available to any commercially insured patient whose plan covers the drug.
-
3
Can I get Ozempic for free? Who qualifies for the Patient Assistance Program? Yes — the NovoCare Patient Assistance Program (PAP) provides Ozempic at no cost · Must be uninsured or have Medicare with no other drug coverage · Household income at or below 200% of the Federal Poverty Level (uninsured) · Must have a valid prescription for a qualifying condition · Cannot be on Medicaid or have other government drug coverageThis is the program most people don’t know exists. Novo Nordisk’s NovoCare Patient Assistance Program provides Ozempic completely free to qualifying individuals with no monthly fee, no registration fee, and no cost whatsoever. To qualify, you must be a U.S. resident, have a valid Ozempic prescription for an FDA-approved indication (primarily type 2 diabetes), have no commercial insurance coverage, and have household income at or below 200% of the Federal Poverty Level — for 2026, that’s roughly $30,120 per year for a single person and $40,880 for a household of two (these figures are updated annually; check needymeds.org for current guidelines). Important change: Medicare Part D patients with coverage are no longer eligible for the PAP as of 2026, since most Part D plans now cover Ozempic. Uninsured Medicare patients who have a denial from Part D can still apply. Your doctor’s office can help you complete the application, which can be submitted by mail or fax. The program has no registration or renewal fees.
-
4
How much does Ozempic cost at Walmart, Costco, or other pharmacies without insurance? Retail pharmacy prices (no discount) range from $800–$1,219/month depending on location and dose · GoodRx coupons reduce this to roughly $825–$950/month at most chains · The NovoCare self-pay price ($349/month) is lower than any coupon at major retail pharmaciesWalking into any pharmacy — Walmart, Costco, CVS, Walgreens, Rite Aid — and paying the sticker price for Ozempic without any discount will cost you between $800 and $1,219 per month depending on your specific pharmacy’s pricing and the dose. GoodRx and similar pharmacy discount cards (SingleCare, RxSaver, Optum Perks) typically bring this down to roughly $825 to $950 per month — a real reduction but still far above the NovoCare self-pay price. The practical takeaway: if you’re uninsured and going to pay out of pocket, ordering through NovoCare Pharmacy directly at $349/month is significantly cheaper than using any coupon at a retail pharmacy. Pharmacy prices vary enough by location that it’s worth comparing — the same medication can differ by $100 or more between two pharmacies in the same zip code. The GoodRx app lets you compare prices at pharmacies near you before you fill.
-
5
Does Medicare cover Ozempic, and how much do Medicare patients pay? Most Medicare Part D plans cover Ozempic for type 2 diabetes · Medicare does NOT cover Ozempic for weight loss only (changing July 2026 for obesity indication) · Medicare patients cannot use the $25 NovoCare Savings Card · The Inflation Reduction Act caps total Part D out-of-pocket costs at $2,000/year · Low-income Medicare patients may qualify for Extra Help or the PAPMedicare coverage of Ozempic is more available than many seniors realize — most Part D prescription drug plans do cover it for type 2 diabetes, though prior authorization may be required. Copays under Part D vary by plan tier but are meaningfully lower than retail prices. The Inflation Reduction Act created a $2,000 annual out-of-pocket cap for Medicare Part D starting in 2025, which limits how much any Medicare patient pays for all covered drugs combined — this has particularly helped patients on expensive medications like Ozempic. One significant development: beginning July 2026, Medicare is expanding coverage of GLP-1 medications to include the obesity indication under expanded Treat and Reduce Obesity Act provisions — meaning seniors who previously couldn’t get Medicare to cover Ozempic because they didn’t have type 2 diabetes may gain new coverage. If you’re on Medicare and struggling with costs, ask your doctor about the Medicare Prescription Payment Plan (M3P), which spreads costs across monthly payments, and check if you qualify for the Extra Help (Low Income Subsidy) program at ssa.gov.
-
6
Is there a 30-day supply of Ozempic pills and how much does it cost? Yes — Ozempic is now also available as a daily tablet · Pill doses: 1.5 mg ($149/month self-pay), 4 mg ($199/month), 9 mg ($299/month) · Same active ingredient (semaglutide) as the injection · FDA-approved for type 2 diabetes · May have different insurance coverage than the injection penThis is a genuinely new development that most people haven’t heard about. Novo Nordisk received FDA approval for Ozempic as a daily oral tablet — same semaglutide active ingredient, same diabetes indication, just in pill form rather than a weekly injection. The oral form comes in three strengths with different self-pay prices through NovoCare: 1.5 mg at $149/month, 4 mg at $199/month, and 9 mg at $299/month. For some patients who are uncomfortable with self-injecting or who have injection-related barriers, the pill represents a real alternative. The pill’s insurance coverage profile may differ from the injection — some plans cover one but not the other, or have the pill on a different formulary tier. Worth asking your pharmacist whether your plan covers the pill vs. the injection differently. Note: this is different from Wegovy (semaglutide for weight loss), which also now has an oral version but at a different dose and indication.
-
7
What happened to compounded semaglutide — is it still available? No — compounded semaglutide is no longer legally available as of 2025 · FDA resolved the Ozempic shortage, ending compounding pharmacy authorization · 503A pharmacies lost authority April 22, 2025; 503B facilities on May 22, 2025 · The FDA has issued over 50 warning letters to compounding pharmacies for violations · Counterfeit GLP-1 products have been documentedCompounded semaglutide was widely available in 2023 and 2024 when Ozempic was officially in a shortage — FDA regulations allowed compounding pharmacies to legally prepare versions of shortage drugs. When the FDA declared the shortage resolved in early 2025, that authorization ended. Since May 2025, compounding pharmacies no longer have legal authority to produce semaglutide compounds for general use. If you encounter a telehealth provider or pharmacy still offering compounded semaglutide, they are operating outside current FDA enforcement boundaries — the FDA has issued over 50 warning letters to noncompliant compounders and has documented counterfeit GLP-1 products in the market. This doesn’t mean every provider offering it is dishonest, but the regulatory risk is real and the product safety is unverified. The practical alternative for cost-conscious patients is now the Novo Nordisk NovoCare self-pay program ($349/month) or the oral Wegovy pill, which Novo Nordisk offers at $199/month for the first two fills through their program.
-
8
My insurance won’t cover Ozempic — what are the next-best options? NovoCare self-pay: $349/month (most doses) · Patient Assistance Program: $0 if income-eligible · Oral Wegovy: $199/month intro through Novo Nordisk (weight loss indication) · Rybelsus (oral semaglutide): different insurance coverage, sometimes lower copay · Trulicity (dulaglutide): weekly GLP-1 injection, sometimes on more favorable insurance tier · Appeal the insurance denial — PA denials are frequently overturnedInsurance denials for Ozempic are common, particularly for weight management use — over 90% of plans cover it for type 2 diabetes but only about 30% cover it for weight management without a diabetes diagnosis. If you’ve been denied, the first step is to appeal. Prior authorization denials for medically appropriate GLP-1 prescriptions are overturned at a meaningful rate when the appeal includes A1C levels, documentation of prior medication trials, and relevant comorbidities like cardiovascular disease or kidney disease (both of which are now FDA-approved indications for semaglutide). Your doctor’s office can assist with this and Novo Nordisk has reimbursement support teams. If an appeal isn’t viable, other GLP-1 medications — Trulicity (dulaglutide) or the oral Rybelsus — may sit on a different formulary tier with better coverage under your specific plan. Ask your pharmacist to check your plan’s formulary for GLP-1 alternatives before assuming none are covered.
This table shows what patients actually pay in different coverage situations. The “list price” column is almost never what anyone pays — it’s included so you can see the gap that savings programs close.
| Who You Are | Monthly Cost | Program / Path |
|---|---|---|
| Uninsured — No discount, retail pharmacy | $936–$1,219List price — avoid this if possible | No program applied. Use NovoCare instead. |
| Uninsured — GoodRx or pharmacy coupon | $825–$950Modest savings vs. retail | GoodRx, SingleCare, RxSaver at major pharmacies. Lower than list price but still much higher than NovoCare. |
| Uninsured — New patient, NovoCare intro BEST FIRST STEP | $199/monthFirst 2 months only (0.25 mg & 0.5 mg) | Order through NovoCare Pharmacy. Self-pay intro offer. No income verification required. |
| Uninsured — NovoCare standard self-pay | $349–$499/month$349 (most doses) · $499 (2 mg) | NovoCare Pharmacy or participating pharmacies. No income verification. Available to all self-pay patients. |
| Low income, uninsured — Patient Assistance Program FREE | $0 / monthMust qualify on income (≤200% FPL) | NovoCare Patient Assistance Program (PAP). Apply at novocare.com. Requires prescription + income docs + Medicaid denial if applicable. |
| Commercial insurance + NovoCare Savings Card LOWEST | As low as $25/monthUp to $100 savings per month · 48 months max | NovoCare Savings Card. Requires commercial insurance that covers Ozempic. Cannot be used with Medicare, Medicaid, or VA. |
| Medicare Part D — Ozempic covered (T2D) | Varies by plan$2,000 annual out-of-pocket cap (IRA) | Most Part D plans cover for T2D. Cannot use NovoCare card. Low-income: apply for Extra Help at ssa.gov. |
| Medicare — Weight loss only (no T2D) CHANGING | Potentially covered July 2026New obesity coverage expansion | Medicare expanding GLP-1 coverage to obesity indication. Check your Part D plan after July 2026. |
| Ozempic Pill (oral) — Self-pay | $149–$299/month1.5 mg · 4 mg · 9 mg daily tablet | NovoCare self-pay pricing for daily tablet form. Same semaglutide ingredient. May have different insurance tier than injection. |
As of May 2025, compounded semaglutide is no longer authorized following FDA resolution of the shortage. Providers still offering it are operating outside current federal law. The FDA has documented counterfeit GLP-1 products in the marketplace. Do not purchase semaglutide from any source that cannot provide proof it is the FDA-approved Novo Nordisk product (Ozempic or Wegovy). Report suspicious products to the FDA at 1-800-FDA-1088.
Use the buttons below to find local diabetes care clinics, endocrinologists who prescribe semaglutide, pharmacies that participate in discount programs, or patient advocacy services near you.
- Step 1: Check your income against the NovoCare Patient Assistance Program guidelines (≤200% of the Federal Poverty Level for uninsured patients). If you qualify, you pay $0. Apply at novocare.com with your doctor’s help — there are no fees of any kind.
- Step 2: If you have commercial insurance, apply for the NovoCare Savings Card at ozempic.com — no income check required. Present it at your pharmacy alongside your insurance to bring your copay to as low as $25/month.
- Step 3: If you’re uninsured but don’t qualify for the PAP, order through NovoCare Pharmacy at $349/month (or $199 for your first two months as a new patient) rather than paying retail pharmacy prices.
- Step 4: If you’re on Medicare and paying full price, call your Part D plan and confirm whether Ozempic is covered for your indication. Apply for Extra Help at ssa.gov if your income is limited — it’s free to apply and meaningfully reduces drug costs.
- Step 5: If your insurance denied coverage, ask your doctor’s office to file a prior authorization appeal. Include A1C results, prior medication history, and any cardiovascular or kidney disease documentation. Denials are frequently overturned on first appeal.
This page is for educational purposes only and does not constitute medical or financial advice. Ozempic (semaglutide) is a prescription medication — only a licensed healthcare provider can prescribe it. All pricing information reflects publicly available program details from Novo Nordisk, NovoCare, and pharmacy sources and may change at any time. Medicare, Medicaid, and PAP eligibility requirements are subject to change — verify current terms directly at novocare.com and ssa.gov. Do not purchase semaglutide from sources that cannot verify it is the FDA-approved product. Report suspected counterfeit medications to the FDA at 1-800-FDA-1088. This page has no affiliation with Novo Nordisk, NovoCare, or any pharmaceutical company.